Company intelligence / Profile preview

CorVista Health

Bethesda, Maryland, United Statescorvista.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

The CorVista System® has received FDA clearance for non-invasive point-of-care diagnosis of significant coronary artery disease and pulmonary hypertension. Clinical validation studies demonstrated high negative predictive value for CAD and strong performance in detecting elevated mean pulmonary artery pressure for PH. Additional modules such as heart failure are under development.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Analytics For Life, Inc. – technology licensor/manufacturerATSS – distribution partnership in Saudi Arabia

Beyond the preview

Go deeper on CorVista Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CorVista Health.

Explore the full profile